Recombinant Dna Biosciences Private Limited, a active private limited company, was established on 20 December 2016 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the hospital and medical care sector, it holds CIN: U74999DL2016PTC309441. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kaushlesh Singh (Director), Piyoosh Mishra (Director), Raju Jaiswal (Director). Past directors included Yogendra Kumar, Rakesh Khurana, Kaushlesh Singh. It holds ₹7.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Tc-681, Ground Floor, Raghubir Nagar, New Delhi, Delhi, 110027.
U74999DL2016PTC309441
309441
20 December 2016
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Recombinant Dna Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kaushlesh Singh | Director | 30 Jan 2024 | Current |
| Piyoosh Mishra | Director | 13 Oct 2017 | Current |
| Raju Jaiswal | Director | 13 Oct 2017 | Current |
| Chandra Kant Maheshwari | Director | 26 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Nov 2017 | Past |
| Pramod Abcsdd | Director | 14 Nov 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Recombinant Dna Biosciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.97% decrease. The company also saw a substantial fall in profitability, with a 26.49% decrease in profit. The company's net worth Soared by an impressive increase of 22.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Recombinant Dna Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2025 | Hdfc Bank Limited | ₹7.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Recombinant Dna Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Recombinant Dna Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recombinant Dna Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 7.50 M with Charge ID 101185993 was registered on 13 Oct 2025. was completed.
The activity Recombinant Dna Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Recombinant Dna Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Kaushlesh Singh was appointed as a Director was appointed as a Director on 30 Jan 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
Chandra Kant Maheshwari was appointed as a Director was appointed as a Director on 26 Jan 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.
Progress on Piyoosh Mishra was appointed as a Director was appointed as a Director on 13 Oct 2017 & has been associated with this company since 8 years 2 months . was documented.
The CIN of Recombinant Dna Biosciences Private Limited is U74999DL2016PTC309441.
Recombinant Dna Biosciences Private Limited is headquartered at Tc-681, Ground Floor, Raghubir Nagar, New Delhi, Delhi, 110027.
Recombinant Dna Biosciences Private Limited was incorporated on 20 December 2016.
The current directors of Recombinant Dna Biosciences Private Limited are
The primary industry of Recombinant Dna Biosciences Private Limited is Hospital And Medical Care.
Recombinant Dna Biosciences Private Limited is unlisted.
The authorized capital of Recombinant Dna Biosciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Recombinant Dna Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX